HYPD.US Hyperion DeFi, Inc.

Healthcare Health Care Providers & Services USA Stocks
2.58 USD
Close of Nov 15, 2026
2.34 5.14
Market cap
USD 39.8M
P/E
-
P/B
0.39x
ROE
37.2%
Dividend yield
2.24%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is HYPD.US undervalued?

Graham number

The Graham number of Hyperion DeFi, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hyperion DeFi, Inc. fundamental analysis

No fundamental analysis for Hyperion DeFi, Inc. yet.

Hyperion DeFi, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hyperion DeFi, Inc.

Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly know…

Full company profile